Likely transmission of hepatitis C virus through sharing of cutting and perforating instruments in blood donors in the State of Pará, Northern Brazil;Possível transmissão do vírus da hepatite C por compartilhamento de materiais cortantes e perfurantes em doadores de sangue no Estado do Pará, Norte do Brasil

Cadernos de Saude Publica

Volumn 26, Issue 4, 2010, Pages 837-844

  de Oliveira Filho, Aldemir Branco ^a   Pimenta, Adriana do Socorro Coelho ^b   Rojas, Márcia de Fátima Maciel ^b   Chagas, Márcia Cristina Munhoz ^b   Crespo, Deborah Maia ^c   Crescente, José Ângelo Barletta ^a   de Lemos, José Alexandre Rodrigues ^a  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b Laboratorio de Testes de Acidos Nucleicos   (Brazil)

^c Secretaria Executiva de Estado de Saúde Pública do Pará   (Brazil)

Author keywords

Blood donors; Hepacivirus; Hepatitis C

Indexed keywords

EID: 77953558725     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/s0102-311x2010000400025     Document Type: Article

References (36)

1. Shepard CW, Finelli L, Alter MJ. Global epidemiol-ogy of hepatitis C virus infection. Lancet Infect Dis 2005; 5:558-67.
2. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007; 13:2436-41.
3. Lo Re 3rd V, Kostman JR. Management of chronic hepatitis C. Postgrad Med J 2005; 81:376-82.
4. Grupo de Estudo da Sociedade Brasileira de He-patologia. Epidemiologia da infecção pelo vírus da hepatite C no Brasil. Gastroenterol End Digest 1999; 18:S3-8.
5. Da Fonseca JCF, Brasil LM. Hepatitis C virus infection in the Amazon Brazilian region. Rev Soc Bras Med Trop 2004; 37:1-8.
6. Campiotto S, Pinho JR, Carrilho FJ, Da Silva LC, Souto FJ, Spinelli V, et al. Geographic distribution of hepatitis C virus genotypes C in Brazil. Braz J Med Biol Res 2005; 38:41-9.
7. Hadziyannis SJ, Koshina, JS. Differences in epidemiology, liver disease and treatment response among HCV genotypes. Hepatol Res 2004; 29:129-35.
8. Zeuzem S. Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well. Ann Intern Med 2004; 140:370-81.
9. Gonçalves FL, Boccato RSBS, Pedro RJ, Papaiordanou PMO, Souza CA, Gonçalves NSL, et al. Prevalence of HBsAg, anti-HBc and anti-HCV in blood donors of "Hemocentro-Campinas". Rev Inst Med Trop São Paulo 1993; 35:45-51.
10. Narciso-Schiavon JL, Schiavon LL, Carvalho-Filho RJ, Freire FCF, Cardoso JR, Bordin JO, et al. Antihepatitis C virus-positive blood donors: are women any different? Transfus Med 2008; 18:175-83.
11. Nascimento MC, Mayaud P, Sabino EC, Torres KL, Franceschi S. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey. J Med Virol 2008; 80:53-7.
12. Bari A, Akhtar S, Rahbar MH, Luby SP. Risk factors for hepatitis C virus infection in male adults in Rawalpindi-Islamabad, Pakistan. Trop Med Int Health 2001; 6:732-8.
13. Memon MI, Memon MA. Hepatitis C: an epidemiological review. J Viral Hepat 2002; 9:84-100.
14. Prati, D. Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol 2006; 45:607-16.
15. Kane M. Unsafe injections. Bull World Health Organ 1998; 76:99-100.
16. Marx MA, Murugavel KG, Sivaram S, Balakrishnan P, Steinhoff M, Anand S, et al. The association of health care use and hepatitis C virus infection in a random sample of urban slum community residents in southern India. Am J Trop Med Hyg 2003; 68:258-62.
17. Hauri AM, Armstrong GL, Hutin YJF. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 2004; 15:7-16.
18. Conte D, Fraquelli M, Prati D, Colucci A, Minola E. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15.250 pregnant wom- en. Hepatology 2000; 31:751-5.
19. Gibb DM, Goodall RL, Dunn DT, Healy M, Neave P, Cafferkey M, et al. Mother-to-child transmission of hepatitis C virus: evidence for preventable peri- partum transmission. Lancet 2000; 356:904-7.
20. Strauss E. Hepatitis C. Rev Soc Bras Med Trop 2001; 34:69-82.
21. Aquino JA, Pegado KA, Barros LP, Machado LFA. Seroprevalence of hepatitis B virus and hepatitis C virus infections among individuals in the State of Pará. Rev Soc Bras Med Trop 2008; 41:334-7.
22. Oliveira-Filho AB, Pimenta ASC, Rojas MFM, Chagas MCM, Crescente JAB, Crespo DM, et al. Preva- lence and genotyping of hepatitis C virus in blood donors in the state of Pará, Northern Brazil. Mem Inst Oswaldo Cruz 2010; 105:103-6.
23. Agência Nacional de Vigilância Sanitária/Ministé- rio da Saúde. Resolução RDC no. 153. http://e-legis.bvs.br/leisref/public/showAct.php?mode=PRINT_VERSION& id=11662 (accessed on 07/Apr/2008).
24. Scott JD, Gretch DR. Molecular diagnostics of hep- atitis C virus infection. A systematic review. JAMA 2007; 297:724-32.
25. Garcia FB, Gomide GPM, Pereira GA, Moraes-Souza H. Importance of screening and confirma-tory tests to detect blood donors infected by the hepatitis C virus. Rev Bras Hematol Hemoter 2008; 30:218-22.
26. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985; 122:904-14.
27. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd Ed. New York: John Wiley & Sons; 2000.
28. Ayres M, Ayres Jr. M, Ayres DL, Santos ASS. BioEstat 5.0: aplicações estatísticas nas áreas das ciências biológicas e médicas [CD-ROM]. Belém: Sociedade Civil Mamirauá/Brasília: Conselho Nacional de Desenvolvimento Científico e Tecnológico; 2005.
29. Lavanchy D. The global burden of hepatitis C. Liver Int 2009; 29:S74-81.
30. Wasley A, Alter MA. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2001; 20:1-16.
31. Mele A, Corona R, Tosti ME, Palumbo F, Moiraghi A, Novaco F, et al. Beauty treatments and risk of par-enterally transmitted hepatitis. Results from the hepatitis surveillance system in Italy. Scand J In-fect Dis 1995; 27:441-4.
32. Koate BBD, Buseri FI, Jeremiah ZA. Seroprevalence of hepatitis C virus among blood donors in Rivers State, Nigeria. Transfus Med 2005; 15:449-51.
33. Reeler AV. Injections: a fatal attraction. Soc Sci Med 1990; 31:1119-25.
34. Arrieta JJ, Rodriguez-Inigo E, Casqueiro M, Barto-lomé J, Manzarbeitia F, Herrero M, et al. Detection of hepatitis C virus replication by in situ hybridiza-tion in epithelial cells of anti-hepatitis C virus-pos-itive patients with and without oral lichen planus. Hepatology 2000; 32:97-103.
35. Hermida M, Ferreiro MC, Barral S, Laredo R, Cas-tro A, Diz Dios P. Detection of HCV RNA in saliva of patients with hepatitis C virus infection by us-ing a highly sensitive test. J Virol Methods 2002; 101:29-35.
36. Madhava V, Burgess C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2002; 2:293-302.